-
1.
公开(公告)号:US20080109512A1
公开(公告)日:2008-05-08
申请号:US11972991
申请日:2008-01-11
申请人: Jianguang ZHOU , Yijiong ZHANG , Xuejiang ZHANG , Jianjun LI
发明人: Jianguang ZHOU , Yijiong ZHANG , Xuejiang ZHANG , Jianjun LI
IPC分类号: G06F15/16
CPC分类号: H04L63/104 , H04L12/2878 , H04L41/0893 , H04L61/2015
摘要: A method and system for implementing network device access management. The system includes at least one device domain storage unit and at least one Access Server (AS), and the method groups all network devices into at least one device domain managed by at least one AS; sets a uniform communication attribute for each device domain; determines, by the AS, whether a communication device belongs to the device domain managed by the AS according to information carried in a service request from the communication device, and if so, the communication attribute set for the network device is obtained, and a correspondence relationship between an identifier of the network device and the obtained communication attributes is created and stored; otherwise, access management on the communication device served as a user device is performed.
摘要翻译: 一种实现网络设备接入管理的方法和系统。 该系统包括至少一个设备域存储单元和至少一个接入服务器(AS),并且该方法将所有网络设备分组成由至少一个AS管理的至少一个设备域; 为每个设备域设置统一的通信属性; 由AS确定通信设备是否属于由AS管理的设备域,根据来自通信设备的服务请求中携带的信息,如果是,则获得为网络设备设置的通信属性,并且通信 创建并存储网络设备的标识符与所获得的通信属性之间的关系; 否则,执行用作用户设备的通信设备上的访问管理。
-
公开(公告)号:US20160075670A1
公开(公告)日:2016-03-17
申请号:US14947458
申请日:2015-11-20
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
IPC分类号: C07D277/68 , C07C53/10
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
-
公开(公告)号:US20150336914A1
公开(公告)日:2015-11-26
申请号:US14817175
申请日:2015-08-03
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
IPC分类号: C07D277/68
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
摘要翻译: 本发明提供游离形式或药学上可接受的盐形式的式(I)化合物,其制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US20150126490A1
公开(公告)日:2015-05-07
申请号:US14527328
申请日:2014-10-29
申请人: Jeffrey T. BAGDANOFF , Yu DING , Wooseok HAN , Zilin HUANG , Qun JIANG , Jeff Xianming JIN , Xiang KOU , Patrick LEE , Mika LINDVALL , Zhongcheng MIN , Yue PAN , Sabina PECCHI , Keith Bruce PFISTER , Daniel POON , Vivek RAUNIYAR , Xiaojing Michael WANG , Qiong ZHANG , Jianguang ZHOU , Shejin ZHU
发明人: Jeffrey T. BAGDANOFF , Yu DING , Wooseok HAN , Zilin HUANG , Qun JIANG , Jeff Xianming JIN , Xiang KOU , Patrick LEE , Mika LINDVALL , Zhongcheng MIN , Yue PAN , Sabina PECCHI , Keith Bruce PFISTER , Daniel POON , Vivek RAUNIYAR , Xiaojing Michael WANG , Qiong ZHANG , Jianguang ZHOU , Shejin ZHU
IPC分类号: C07D498/04 , A61K31/497 , A61K45/06 , C07D401/04 , A61K31/4545 , C07D405/14 , A61K31/506 , C07D409/04 , A61K31/4436 , A61K31/5383 , C07D241/20 , A61K31/4965 , A61K31/4439 , C07D413/14 , A61K31/5377 , A61K31/553 , C07D405/04
CPC分类号: A61K31/497 , A61K31/44 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/4545 , A61K31/4965 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/5383 , A61K31/553 , A61K45/06 , A61K2121/00 , C07D213/73 , C07D241/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/14 , C07D498/04
摘要: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
摘要翻译: 本发明提供式(I)的化合物或其盐; 和这些化合物的治疗用途。 本发明还提供包含这些化合物的药物组合物,以及包含这些化合物与治疗性助剂的组合物。
-
公开(公告)号:US20170182038A1
公开(公告)日:2017-06-29
申请号:US14964057
申请日:2015-12-09
申请人: Jeffrey T. BAGDANOFF , Yu DING , Wooseok HAN , Zilin HUANG , Qun JIANG , Xianming JIN , Xiang KOU , Patrick LEE , Mika LINDVALL , Zhongcheng MIN , Yue PAN , Sabina PECCHI , Keith Bruce PFISTER , Daniel POON , Vivek RAUNIYAR , Xiaojing Michael WANG , Qiong ZHANG , Jianguang ZHOU , Shejin ZHU
发明人: Jeffrey T. BAGDANOFF , Yu DING , Wooseok HAN , Zilin HUANG , Qun JIANG , Xianming JIN , Xiang KOU , Patrick LEE , Mika LINDVALL , Zhongcheng MIN , Yue PAN , Sabina PECCHI , Keith Bruce PFISTER , Daniel POON , Vivek RAUNIYAR , Xiaojing Michael WANG , Qiong ZHANG , Jianguang ZHOU , Shejin ZHU
IPC分类号: A61K31/497 , A61K31/5355 , A61K31/4436 , A61K31/4433 , A61K31/44
CPC分类号: A61K31/497 , A61K31/44 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/4545 , A61K31/4965 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/5383 , A61K31/553 , A61K45/06 , A61K2121/00 , C07D213/73 , C07D241/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/14 , C07D498/04
摘要: The present invention provides a compound of Formula (I) or a salt thereof; and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
-
公开(公告)号:US20130245080A1
公开(公告)日:2013-09-19
申请号:US13603990
申请日:2012-09-05
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
IPC分类号: A61K31/428 , A61K45/06 , C07D277/68
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
-
公开(公告)号:US20160279107A1
公开(公告)日:2016-09-29
申请号:US15178579
申请日:2016-06-10
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd Ulrich RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang Wu , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd Ulrich RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang Wu , Jianguang ZHOU
IPC分类号: A61K31/428
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
摘要翻译: 制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US20150094346A1
公开(公告)日:2015-04-02
申请号:US14566021
申请日:2014-12-10
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Philipp LUSTENBERGER , Bernd RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang WU , Jianguang ZHOU
IPC分类号: C07D277/68 , A61K31/167 , A61K31/428
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
-
-
-
-
-
-
-